Advertisement
U.S. markets open in 4 hours 19 minutes
  • S&P Futures

    5,213.75
    -1.00 (-0.02%)
     
  • Dow Futures

    39,221.00
    -2.00 (-0.01%)
     
  • Nasdaq Futures

    18,229.75
    -1.75 (-0.01%)
     
  • Russell 2000 Futures

    2,045.40
    -4.40 (-0.21%)
     
  • Crude Oil

    82.81
    +0.09 (+0.11%)
     
  • Gold

    2,155.80
    -8.50 (-0.39%)
     
  • Silver

    25.09
    -0.17 (-0.69%)
     
  • EUR/USD

    1.0848
    -0.0028 (-0.26%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.42
    +0.09 (+0.63%)
     
  • GBP/USD

    1.2686
    -0.0043 (-0.34%)
     
  • USD/JPY

    150.4040
    +1.3060 (+0.88%)
     
  • Bitcoin USD

    63,167.47
    -4,510.16 (-6.66%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,719.76
    -2.79 (-0.04%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Natus Medical Inc (BABY) Files 10-K for the Fiscal Year Ended on December 31, 2017

- By insider

Natus Medical Inc (BABY) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Natus Medical Inc provides newborn care & neurology healthcare products & services used for screening, diagnosis, detection, treatment, monitoring & tracking of medical ailments in newborn care, epilepsy, sleep disorders, and balance & mobility disorders. Natus Medical Inc has a market cap of $968.900 million; its shares were traded at around $31.10 with and P/S ratio of 2.05. Natus Medical Inc had annual average EBITDA growth of 13.80% over the past ten years.


For the last quarter Natus Medical Inc reported a revenue of $131.4 million, compared with the revenue of $107.7 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $501.0 million, an increase of 31.2% from last year. For the last five years Natus Medical Inc had an average revenue growth rate of 9.1% a year.

The reported loss per diluted share was 62 cents for the year, compared with the earnings per share of $1.14 in the previous year. The Natus Medical Inc had an operating margin of 1.74%, compared with the operating margin of 14.47% a year before. The 10-year historical median operating margin of Natus Medical Inc is 9.64%. The profitability rank of the company is 6 (out of 10).

At the current stock price of $31.10, Natus Medical Inc is traded at 18.3% discount to its historical median P/S valuation band of $38.07. The P/S ratio of the stock is 2.05, while the historical median P/S ratio is 2.49. The stock lost 15.87% during the past 12 months.

For the complete 20-year historical financial data of BABY, click here.

This article first appeared on GuruFocus.


Advertisement